Joseph P. ST. LAURENT,Gerald S. JONES,David M. BRESSE
申请号：
US15260554
公开号：
US20170065542A1
申请日:
2016.09.09
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and ω-(methylsulfonyl)alkylamine or ω-(methylsulfonyl)alkylamide. The present invention is also directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering ω-(methylsulfonyl)alkylamine or ω-(methyl sulfonyl)alkylamide, or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof.
